AMTAGVI Trademark
AMTAGVI is a USPTO trademark filed by Iovance Biotherapeutics, Inc.. Status: Registered.
Prosecution Summary
**Trademark Summary** The USPTO registration for **AMTAGVI** covers biological preparations for the treatment of immune system related and oncological diseases and disorders, and related services including providing medical information relating to oncology and immunotherapy treatment; providing medical information; medical consultations; and isolation and collection of human biological tissue for immunotherapy. The mark is currently **registered** (registration date **December 3, 2024**). The owner listed is **Iovance Biotherapeutics, Inc.** No active opposition or other legal proceeding is indicated in the provided record. **Recent Activity** The application was filed on **May 15, 2020** and was **published for opposition** on **September 29, 2020**. Key prosecution milestones includ
Trademark Facts
| Mark | AMTAGVI |
|---|---|
| Serial Number | 88918260 |
| Registration Number | 7588640 |
| Status | Registered |
| Filing Date | 2020-05-15 |
| Registration Date | 2024-12-03 |
| Mark Type | Word |
| Nice Classes | 005 (Pharmaceuticals), 044 (Medical Services) |
| Owner | Iovance Biotherapeutics, Inc. |
| Attorney of Record | Carla B. Oakley |
| Prosecution Events | 53 |
| Latest Event | REAP on 2026-04-07 |
Goods & Services
biological preparations for the treatment of immune system related and oncological diseases and disorders | providing medical information relating to oncology and immunotherapy treatment; providing medical information; medical consultations; isolation and collection of human biological tissue for immunotherapy